Have a personal or library account? Click to login
Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility Cover

Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility

Immunohematology
Volume 29 (2013): Issue 4 (December 2013)
By: H.M. Smith,  R.S. Shirey,  S.K. Thoman and  J.B. Jackson  
Paid access
|Dec 2019

Authors

H.M. Smith

Clinical Laboratory Scientist III, Baltimore, MD, USA

R.S. Shirey

Technical Specialist II, Baltimore, MD, USA

S.K. Thoman

Laboratory Supervisor, Baltimore, MD, USA

J.B. Jackson

Director of Pathology, Division of Transfusion Medicine, Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA
DOI: https://doi.org/10.21307/immunohematology-2019-134 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 127 - 130
Published on: Dec 1, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prevalence,
red blood cell alloantibodies,
pregnant women
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2019 H.M. Smith, R.S. Shirey, S.K. Thoman, J.B. Jackson, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 29 (2013): Issue 4 (December 2013)Next article